| 发明名称 |
Method of Adjuvant Cancer Treatment |
| 摘要 |
The present invention provides a method of providing adjuvant treatment to a human patient which comprises administering to such a patient therapeutically effective doses of dabrafenib and trametinib for a time period sufficient to increase relapse-free survival (RFS). |
| 申请公布号 |
US2015216868(A1) |
申请公布日期 |
2015.08.06 |
| 申请号 |
US201314422182 |
申请日期 |
2013.08.30 |
| 申请人 |
GlaxoSmithKline LLC |
发明人 |
Laquerre Sylvie;Lebowitz Peter F. |
| 分类号 |
A61K31/519;A61K31/506 |
主分类号 |
A61K31/519 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of providing adjuvant treatment to a patient with a prior diagnosis of melanoma which has been resected, comprising the step of administering to such a patient therapeutically effective doses of dabrafenib and trametinib for a time period sufficient to increase relapse-free survival (RFS). |
| 地址 |
Wilmington DE US |
